When was Filtravate founded?

Filtravate was founded in 2020.

Where is Filtravate located?

Filtravate is headquartered in Las Cruces, United States.

How many employees does Filtravate have?

As of Aug 31, 2026, the latest employee count at Filtravate is 1.

Is Filtravate a funded company?

Filtravate is a funded company, having raised a total of $300K across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round.

When was the latest funding round of Filtravate?

Filtravate's latest funding was a $***** Grant (prize money) round on Sep 15, 2022, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.62B in funding in 2026 to date.

Where does Filtravate rank among its competitors?

Filtravate ranks 8th amongst 22 active competitors, of which 4 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Tanda Biotech, which secured $75K in Feb, 2026.

Who are the top competitors of Filtravate?

Filtravate's top competitors include Cytosorbents, TeraPore and SANI Membranes. Among them, Tanda Biotech secured the most recent funding round in February, 2026.

Filtravate - 2026 Company Profile, Team, Funding & Competitors

Filtravate is a seed company based in Las Cruces (United States), founded in 2020 by Reza Foudazi. It operates as a Provider of ultrafiltration membranes for bioprocessing and pharmaceutical industries. Filtravate has raised $300K in funding from VIC Technology Venture Development. The company has 22 active competitors, including 4 funded and 3 that have exited. Its top competitors include companies like Cytosorbents, TeraPore and SANI Membranes.

Company Details

Provider of ultrafiltration membranes for bioprocessing and pharmaceutical industries. The company uses proprietary technology to develop membranes with controlled and tunable pore size, even pore distribution, and functionalized surfaces.

Website: filtravate.com
Email ID: *****@filtravate.com
Phone Number: +1 **********
Part Of

Key Metrics

Founded Year

2020

Location

Las Cruces, United States

Stage

Seed

Total Funding

$300K in 3 rounds

Latest Funding Round

Grant (prize money), Sep 15, 2022, $*****

Investors

VIC Technology Venture Development & 1 more

Ranked

8^th among 22 active competitors

Employee Count

1 as on Aug 31, 2026

Similar Companies

Cytosorbents & 22 more

View Filtravate's full profile

Filtravate is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Filtravate, Inc. CIN: 851114077 , United States, Active	Dec 31, 2019	-	-	-

Filtravate has raised a total funding of $300K over 3 rounds. Its latest funding round was a Grant (prize money) round on Sep 15, 2022 for $*****. 1 investor participated in its latest round. Filtravate has 2 institutional investors.

Here is the list of recent funding rounds of Filtravate:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 15, 2022	6436102	Grant (prize money)	2512491	7019155	1241534	9612116
Feb 17, 2022	7687749	Seed	7011407	1776818	2866880	7141741

Access funding benchmarks and valuations. Sign up today!

View details of Filtravate's funding rounds and investors

The founders of Filtravate is Reza Foudazi.

Here are the details of Filtravate's key team members:

Reza Foudazi: Founder of Filtravate.

View details of Filtravate's Founder profiles and Board Members

Filtravate's employee count trend

Filtravate has 1 employees as of Aug 26. Here is Filtravate's employee count trend over the years:

Uncover Filtravate's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Filtravate include Cytosorbents, TeraPore and SANI Membranes. Here is the list of Top 10 competitors of Filtravate, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Cytosorbents 1997, Monmouth Junction (United States), Public	Developer of hemoperfusion technology for removing toxins from the blood	$22M	Western Alliance Bank, NJTC Venture Fund & 5 others	66/100
2nd	TeraPore 2013, San Francisco (United States), Series B	Developer of bioseparation solutions for therapeutics and novel biologics	$19.5M	Anzu Partners, RA Capital Management & 8 others	46/100
3rd	SANI Membranes 2013, Vaerlose (Denmark), Unfunded	Developer of advanced filtration systems for bimolecular separation	-	-	31/100
4th	Szmeizhao 2002, Shenzhen (China), Funding Raised	Provider of integrated solutions for digital hospital environment and energy management	-	Dami Ventures, China Investment LuckyStone Management ... Read more	31/100
5th	Hermes Bioscience 2024, San Francisco (United States), Seed	Developer of benchtop extracellular vesicle isolation technology to purify exosomes	-	Genoa Ventures, Vertical Venture Partners ... & 1 others	29/100
6th	Sublin 2018, Oss (Netherlands), Series B	Developer of needle free insulin delivery system using nanotechnology based encapsulation	-	-	28/100
7th	Membrana 1998, Charlotte (United States), Acquired	Manufacturer of filtration membranes for life sciences industries	-	-	28/100
8th	Filtravate 2020, Las Cruces (United States), Seed	Provider of ultrafiltration membranes for bioprocessing and pharmaceutical industries	$300K	National Science Foundation, VIC Technology Venture Development ... Read more	27/100
9th	Tanda Biotech 2023, Buffalo Grove (United States), Funding Raised	Developer of filtration technologies for biomanufacturing scalability and cost efficiency	-	Illinois Science Technology, National Science Foundation ... Read more	26/100
10th	mdi Membrane Technologies 2014, Harrisburg (United States), Unfunded	Membrane technology company providing filtration and separation solutions for biopharma	-	-	26/100